NCT02253199View on ClinicalTrials.gov

The Effect of Age on the Median Effective Dose (ED50) of Intranasal Dexmedetomidine for Rescue Sedation Following Failed Sedation With Oral Chloral Hydrate During Magnetic Resonance Imaging

PHASE4CompletedINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

October 31, 2014

Primary Completion Date

February 29, 2016

Study Completion Date

March 31, 2016

Conditions
AgedDrugDose-Response Relationship
Interventions
DRUG

intranasal dexmedetomidine

"Children who were not adequately sedated ( no evidence of adequate sedation within 30 min after administration of Initial dose of chloral hydrate) received a bolus of intranasal dexmedetomidine which adjusted by the Dixon up-and-down method for rescue sedation.~The first child received 0.8mcg/Kg of intranasal dexmedetomidine dose (100mcg/ml), and the dose interval was set at 0.1mcg/Kg."

Trial Locations (1)

510000

Department of Anesthesiology of Guangzhou Women and Children's Medical Center, Guangzhou

All Listed Sponsors
lead

Guangzhou Women and Children's Medical Center

OTHER

NCT02253199 - The Effect of Age on the Median Effective Dose (ED50) of Intranasal Dexmedetomidine for Rescue Sedation Following Failed Sedation With Oral Chloral Hydrate During Magnetic Resonance Imaging | Biotech Hunter | Biotech Hunter